| Laboratory | Exult Diagnostics, Dr. Lal PathLabs, Metropolis Labs, Oncquest Labs, Pathkind Labs |
|---|
Price range: ₹ 3400 through ₹ 5200
| EX1719 PLASMA RENIN, DIRECT | |||||||
| Specimen: | 3 mL (2.5 mL min.) plasma from 1 Lavender Top (EDTA) tube. | ||||||
| Stability: |
|
||||||
| Method: | CLIA | ||||||
| Comment: | Also see ANGIOTENSIN II. | ||||||
| Report: | Contact us to know the TAT. | ||||||
| Usage: | Renin is a proteolytic enzyme released from juxtaglomerular cells of the kidney. The enzyme cleaves a substrate to produce Angiotensin I which in turn produces Angiotensin II. This metabolite plays a key role in various forms of hypertension. Increased levels are seen in Renal hypertension, Addison’s disease, and Secondary hypoaldosteronism. Low levels are detected in Hyporeninemic hypoaldosteronism and Primary aldosteronism. | ||||||
| Doctor Specialty: | Nephrologist | ||||||
| Disease: | Disorders of Kidney | ||||||
| Components: | |||||||
| Courier Charges: | 0.00 | ||||||
| Home Collection: | Available (*T&C Apply) | ||||||
| Department: | Biochemistry | ||||||
| Pre Test Information: | The patient should be ambulatory/upright 2 hours prior to the test. Drug interactions to be noted: Potassium wasting diuretics, Spironolactone, Eplerenone, Amiloride, and Triamterene should be discontinued for at least for 4 weeks; Adrenergic blockers, Clonidine, Methyldopa, NSAIDs, Angiotensin-converting enzyme inhibitors, Angiotensin receptor blockers, Renin inhibitors, and Dihydropyridine calcium channel antagonists should be discontinued for 2 weeks. If necessary to maintain hypertension control, patients should be treated with other antihypertensive medications like Verapamil slow-release, Hydralazine, Prazosin, Doxazosin & Terazosin that have lesser effects on Plasma renin levels. Any change in medication should be done in consultation with the treating clinician. | ||||||
Reviews
There are no reviews yet.